Halo Therapeutics develops antivirals to prevent users from sickness.
Halo Therapeutics has raised $1.9M in total funding. The most recent round was Seed. The last funding was announced in May 2023.
Halo Therapeutics's investors include Development Bank of Wales, KBA Group, Jonathan Matlock.
Halo Therapeutics is headquartered in Bristol, United Kingdom.
Halo Therapeutics develops antivirals to prevent users from sickness.
Halo Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Halo Therapeutics — Funding & Investors." VCBacked, May 17, 2023, https://www.vcbacked.co/company/halo-therapeutics. Accessed September 30, 2026.
VCBacked. (2023). Halo Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/halo-therapeutics
{{cite web |title=Halo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/halo-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated